Stock Ratings / Financials / UBS / dividends

COF (68) MFG (60) BNS (66) C (39) ⌘ Pro Terminal →

UBS Group AG Registered (UBS) Dividend Safety Gauge & 10-Year DRIP Compounder

$47.69 -0.91% NYSE • Live Quote vs Prior Daily Close (Synced Snapshot) EXT / AFTER-HRS: $47.52

UBS Group AG Registered (UBS) carries a Roarable Rating of D+ (Sell) with 58/100 RQD Confidence due to weak cash-flow efficiency and sensitivity to current interest rates. Wait for business cash flow and institutional buying to improve before committing fresh capital.

📊 Historical Track Record: Scores of 58/100 (D+) historically posted market-perform odds over rolling 90-day windows (+0.0% avg 90D alpha vs SPY) →

ROARABLE D+ • SELL / AVOID Cap $149.37B

📤 Share Live RQD Speedometer Card: 𝕏 Post Reddit StockTwits ⬇ Live SVG Card

⚡ INSTANT AI QUANT PREVIEW • $0 FREE TIER Click Any Pre-Computed AI Quant Specialist Briefing on UBS Below — or Connect Your Own ChatGPT / Claude

🤖 Mara Quenwick • AI Quant Lead (Click for Instant Brief) Is UBS stock a Buy, Hold, or Sell right now according to Roarable's RQD model?

▼

As of 2026-11-02, UBS Group AG Registered (NYSE: UBS) is rated D+ (Sell / SELL) by Roarable's 5-pillar RQD engine with a composite confidence score of 58/100 at a spot price of $47.69 (-0.91% 1D, market cap $149.37B). Pillar breakdown: Fundamental Cash Engine 12/20, Institutional 13F & Options Flow 10/20, Executive Insider Alignment 15/20, FRED Macro Regime Fit 9/20, and SEC Balance-Sheet Forensics 12/20. Across 1096 tracked Financials issuers, UBS ranks #475 in composite RQD confidence.

✓ Pre-computed one-to-many AI Quant brief

🤖 Ellis Vennor • AI Peer & Flow Quant (Click for Instant Brief) How does UBS compare to COF and MFG in the Financials sector?

▼

Within the Financials sector (Major Banks), UBS carries a Roarable D+ (58/100 RQD), trailing P/E of 32.8x, gross margin of —, and ROIC of 9.9%. By comparison, COF (Capital One Financial Corporation) holds a C+ grade (68/100 RQD, P/E 52.2x, ROIC 0.9%, cap $128.06B) and MFG (Mizuho Financial Group Inc. Sponosred ADR (Japan)) posts a C- grade (60/100 RQD, P/E 32.8x, ROIC 9.9%, cap $124.37B). Among the 5-stock peer group, C leads on earnings multiple (14.7x) while UBS leads on capital efficiency (9.9% ROIC).

✓ Pre-computed one-to-many AI Quant brief

🤖 Gideon Ashmere • AI SEC 10-K Forensics (Click for Instant Brief) What are the biggest fundamental strengths and SEC risk factors for UBS?

▼

For UBS Group AG Registered (UBS), key quantitative strengths include Clean SEC annual filing review with no major hidden accounting time-bombs. and sector rank #475 in Financials, while primary risk factors center on Sensitive to high interest rates and tighter Federal Reserve market liquidity. and implied 5-year growth hurdle of 25.3%/yr. Institutional options positioning shows a 50% call / 50% put premium split.

✓ Pre-computed one-to-many AI Quant brief

🤖 AI Quant Disclosure: Roarable Analysts are proprietary AI Quant Specialists — not human financial advisors. Pre-computed one-to-many briefings above are free; interactive 1-on-1 Q&A, custom AI sifting/indicator alerts, and personal ChatGPT/Claude MCP connections require a $9.95/mo Pro account (currently waitlist-only).

INTERACTIVE SCENARIO DECK:

🛡️ Portfolio Crash X-Ray

EXT / AFTER-HRS: $47.52 (-0.35%)🧬 Cannibal Buyback (-1.24% YoY Shares)⚙️ Cash Engine: 12/20 (C-) • 15.8% FCF Margin

Verify 90D Bucket Audit →

📊 Historical Track Record: Scores of 58/100 (D+) historically posted market-perform odds over rolling 90-day windows (+0.0% avg 90D alpha vs SPY • 52.7% hit rate — wait for RQD ≥ 70 breakout).

Audit Bucket Track Record →

RQD QUANT TACHOMETERSELL / AVOID • D+

JEV AI Jury Split (Battleground)

Cash

SEC

Whale

Impersonal quantitative research (0–100 RQD rubric) — not individualized investment advice. Past performance does not guarantee future results. Full Disclaimer

5-PILLAR SNOWFLAKE RADARRw D+ · Rk C-

Each axis scored 0–20

12M PRICE TARGET CONE+0% Base Target

WHALE OPTIONS SNAPSHOT: — (No Active Options Snapshot on file for UBS)Realized 20D OHLCV Swing Band: ±3.5%

Deterministic 5-Pillar Attribution (58/100 Composite)

🔍 WHY UBS SCORES 58/100 (D+) — TOP 3 DRIVERS2 Bullish Pillars + #1 Risk Drag

▲ #1 Bullish Driver: SEC 10-K Forensic Risk+15/20 pts (26% of score)

Altman Z-Score 3.80 (FORTRESS SAFE (>3.0)) • Piotroski F-Score 7/9

▲ #2 Bullish Driver: Cash Engine Quality+12/20 pts (21% of score)

SEC XBRL Trailing 12 Months: 15.8% FCF Margin ($3.30B FCF) & 52% Gross Margin

▼ #1 Drag / Risk Factor: Macro Regime Fit9/20 pts (-11 pt drag)

Macro rate sensitivity & RSI-14 (50.1) create a -11 pt regime headwind

📈 PAST 4 QUARTERS RQD vs SUBSEQUENT RETURNQ1 → Q2 → Q3 → Current

Q1 (-3Q)

Grade B-$47.85-1.3% Next Q

Q2 (-2Q)

Grade C+$47.23-0.9% Next Q

Q3 (-1Q)

Grade C$46.79+1.9% Next Q

Current

Grade D+$47.69+0% Hist 90D α

Trajectory: B- (66) → D+ (58)Full Audit →

⚔️ ADVERSARIAL OPPOSING CASE & FORENSIC KILL-SWITCH (WHY THE BULL/BEAR THESIS COULD FAIL)GIDEON ASHMERE // FORENSIC SHORT & KILL-SWITCH DOSSIER

⚔️ Adversarial Opposing Case: Why the UBS Bull Thesis Could Fail

Gideon Ashmere Forensic Desk →

Even with a 58/100 (D+) score, UBS faces multiple-compression risk if 32.8x trailing P/E re-rate toward historical sector medians or if hyperscaler/enterprise customer concentration slows in upcoming 10-Q filings.

⚠️ Forensic Kill-Switch #1

Sensitive to high interest rates and tighter Federal Reserve market liquidity.

⚠️ Forensic Kill-Switch #2

Dilution & Margin Drag: Cannibal Buyback (-1.24% YoY Shares) — any gross margin slip below 49.5% triggers an automatic RQD downgrade.

⚠️ Forensic Kill-Switch #3

Technical & Forensic Kill-Switch: A daily close below the 50D SMA ($50.01) or 200D SMA ($47.08) invalidates the momentum regime and cuts Target Base ($47.69) toward Bear Floor ($37.20).

🎲 LIVE PREDICTION MARKET ODDS TIED TO $UBS• $2.4M Crowd Pool • Kalshi / Polymarket Composite

Contract: “UBS Beats Next Quarter EPS Consensus (Upcoming Quarter) & Holds Above 200D SMA”

YES 58%NO 42%Trade / Inspect Odds →

CASH DIVIDEND + BUYBACK YIELD

1.8% Total Yield

0% Cash ($0.00/yr) + 1.8% Buybacks

PAYOUT SAFETY SPEEDOMETER

74/100 • REINVESTING IN GROWTH + BUYBACKS

FREE CASH FLOW PAYOUT RATIO

0% (100% Reinvested)

Retains cash flow for R&D and share repurchases

INTERACTIVE DRIP & SHAREHOLDER-YIELD COMPOUNDER (5.5% EST. ANNUAL)

$10,000 Compounded Over 10 Years → $17,081

Est. Year-10 Shareholder Yield: $307/yr

Starting Investment: $10,000

Compounding Horizon: 10 Years

$10.6K

Yr 1

$11.1K

Yr 2

$11.7K

Yr 3

$12.4K

Yr 4

$13.1K

Yr 5

$13.8K

Yr 6

$14.5K

Yr 7

$15.3K

Yr 8

$16.2K

Yr 9

$17.1K

Yr 10

ON-DEMAND RQD QUANT WORKSHOP • SPONSORED / PARTNER SPOTLIGHTHosted by Perry Belcher & Roarable Forensic Quant Desk

Red-Light Warning Desk: Spotting SEC Cash-Flow & Dilution Risks Before Downgrades (Featuring UBS)

✓Walkthrough of UBS's RQD Radar, SEC cash-conversion gap & downside invalidation levels
✓3 asymmetric Bear/Hedge frameworks when 10-year Treasury yields stay elevated
✓Includes nightly RQD rating-change & forensic signal email alerts on your tracked stocks

RQD INSIDER CLUB WAITLIST$49/YR PLANNED

Want Custom AI PineScript / Python Indicators & Priority Rating-Change Alerts?

Join Founding VIP Waitlist (No Card Required) →$100K Arena

UBS // CANDLESTICK & AUTO-TRENDLINE WORKSTATION6M: +9.99%📐 HORIZONTAL RANGE

2026-11-02O $46.69H $48.13L $46.69C $47.69VOL 2.17M

RES: $57.14SUP: $45.79SMA50: $50.01SMA200: $47.08

PRIMARY-SOURCE FORENSICS, SECOND-ORDER LINKS & AI ANALYST DESK

UBS Dilution Monitor, Expectations Hurdle, Butterfly Connections & Policy Exposure

🦋 UBS Butterfly Map → + Track UBS →

Share Count & Dilution Monitor (#25)

Multi-year comparable XBRL diluted share count not disclosed (ETF or recent listing).

Reverse-DCF Expectations Hurdle (#30)

25.3%/yr Implied 5Y Growth

vs. +1.1% actual YoY revenue growth (assuming 9.25% cost of equity & 16.5x terminal multiple).

Ellis Vennor Setup Ledger (#33)

No active Ellis Vennor swing setup published on UBS today. View full Setup Ledger →

🦋 Documented & Second-Order Butterfly Connections Open Graph →

No direct multi-tier Butterfly edges indexed yet for UBS. Explore sector supply chains on /butterfly.

AI Analyst Theses, Washington Policy & Company Video

🎬 No recent verified company-specific video clip queued for UBS today (we never pad ticker pages with unrelated generic clips). Browse Macro Video Desk →

DETERMINISTIC MULTI-FACTOR EQUITY AUDIT • SEC EDGAR XBRL × RQD PEER BENCHMARK

📊 Quantitative Sector Peer Comparison, SEC Filing Delta & Investment FAQ (UBS)

Financials Rank #475 of 1096 ⚔️ COF vs UBS Full Matrix →

1. Head-to-Head Financials Peer Comparison (UBS vs. COF, MFG, BNS, C)

Industry: Major Banks (248 Tracked Issuers)

Across 1096 tracked Financials securities in the Roarable RQD universe, UBS Group AG Registered (UBS) ranks #475 by composite RQD confidence (58/100, grade D+) and #19 by equity capitalization ($149.37B). Within this direct 5-issuer industry benchmark cohort, C leads on earnings valuation at 14.7x trailing P/E, while UBS leads on capital efficiency and profitability with 9.9% ROIC and — gross margin. COF currently holds the highest overall quantitative score in the immediate peer group at 68/100 (C+) compared with UBS at 58/100 (D+).

Ticker / Company	Roarable Grade	RQD Score	Trailing P/E	Gross Margin	ROIC	1D Change	Market Cap	Head-to-Head
UBS ACTIVE UBS Group AG Registered	D+	58/100	32.8x	—	9.9%	-0.91%	$149.37B	Benchmark Subject
COF Capital One Financial Corporation	C+	68/100	52.2x	—	0.9%	-1.86%	$128.06B	/cof-vs-ubs →
MFG Mizuho Financial Group Inc. Sponosred ADR (Japan)	C-	60/100	32.8x	—	9.9%	-3.30%	$124.37B	/mfg-vs-ubs →
BNS Bank Nova Scotia Halifax Pfd 3	C+	66/100	32.8x	—	9.9%	-1.73%	$117.05B	/bns-vs-ubs →
C Citigroup Inc.	D-	39/100	14.7x	—	1.5%	-2.48%	$210.95B	/c-vs-ubs →

2. UBS Fundamental Profitability, Capital Efficiency & Balance-Sheet Forensics

TRAILING 12M & FORWARD QUANTITATIVE SNAPSHOT

UBS Group AG Registered (UBS) operates in Major Banks (Financials) with an equity capitalization of $149.37B, trailing P/E of 32.8x, forward P/E of 30.5x, and EV/EBITDA of 21.0x. Operating profitability registers a gross margin of —, operating margin of 13.9%, net profit margin of 10.9%, ROIC of 9.9%, and free cash flow yield of 2.21%, alongside an Altman Z-Score of N/A and Piotroski F-Score of 7/9.

3. UBS Data-Verified Investor FAQ (RQD Rating, Sector Peers, SEC Forensics & Technicals)

✓ SCHEMA.ORG FAQPAGE JSON-LD ENABLED

Is UBS stock a Buy, Hold, or Sell right now according to Roarable's RQD model?

How does UBS compare to COF and MFG in the Financials sector?

What are the biggest fundamental strengths and SEC risk factors for UBS?

Where is UBS trading relative to its 50-day, 200-day, and 52-week technical levels?

UBS last traded at $47.69 (-0.91% on volume of 2,675,612 shares), positioning the stock -4.64% below its 50-day simple moving average ($50.01) and +1.30% above its 200-day simple moving average ($47.08). Across its 52-week range of $36.29 to $55.99, UBS sits at the 57.9% percentile with a 14-day RSI of 50.1 (NEUTRAL RANGE) and an implied next-earnings move of ±3.5% ($46.02 to $49.36).

UBS Investor FAQ & Complete 8-Part Research Index

100% OPEN ACCESS • SEC EDGAR × CBOE × FRED

Does UBS pay a dividend and is it safe?

UBS Group AG Registered (UBS) offers a 0% cash dividend yield ($0.00 annualized) and 1.8% total shareholder yield including buybacks. Roarable rates its payout coverage as REINVESTING IN GROWTH + BUYBACKS.

Direct Sub-Reports: UBS RQD Cockpit UBS 12M Forecast UBS Earnings & Move UBS Dividends & DRIP UBS Insiders & 13F UBS Whale Options UBS Profit Sankey UBS News & Why

ROARABLE RATING BRIEF • RQD 58/100 (D+) ✓ STAGE-C NUMBER FIREWALL VERIFIED

UBS — UBS Group AG Registered: What the Facts Mean to a Prospective Investor

Engine: anthropic/claude-haiku-5.5

As of: 2026-11-02T14:07:57Z

Roarable Rating Brief: What This Means to a Prospective Investor

Per the Roarable RQD rating, UBS scores 58 out of 100, equivalent to a D+ grade with the verdict label "Roarable Sell — Weak Fundamentals / Trim." Across the five pillars, the Fundamental Cash Engine scores 12 of 20 (ROIC 9.9%; FCF yield 2.21%), suggesting modest returns on invested capital and a thin free-cash-flow yield relative to the $149.37B market capitalization. Whale 13F Flow scores 10 of 20, reflecting institutional accumulation and options positioning that the source does not quantify further. Insider Conviction scores 12 of 20 based on SEC Form 4 and Congressional PTR cluster flow, without detail on direction or size in the source. Macro Regime Fit scores 9 of 20 with a Beta of 0.94 and a sector sensitivity reading, indicating the stock tracks broader market movement closely with limited defensive offset. Forensic Balance Sheet scores 15 of 20, the strongest pillar, with Altman Z of 2.5, Piotroski F of 7/9, and Debt/Equity of 0.5. For a prospective investor, the upside case rests mainly on balance-sheet resilience and the modest ROIC, while the valuation tradeoff is significant: a trailing P/E of 32.8 and forward P/E of 30.5 are high relative to the 9.9% ROIC and 2.21% FCF yield, and the 0% dividend yield provides no income cushion. Second-order implications are that any multiple compression would not be offset by cash yield, and the low macro-regime score limits the stock's ability to outperform in a risk-off environment.

Snapshot

Price	Market Cap	P/E (TTM)	Forward P/E	EV/EBITDA	EPS (TTM)	Dividend Yield	Beta	52-Wk Range	ROIC %
48.13	$149.37B	32.8	30.5	21	1.47	0%	0.94	$36.29 - $55.99	9.9%

Business

UBS Group AG Registered is classified per the profile section as operating in the Financials sector and the Major Banks industry, listed on the NYSE. Not available in source data for specific products, customer segments, or revenue model. The source identifies the company only at the sector and industry level.

Butterfly Effect: 2nd-Order Supply-Chain & Sector Ripples

Per the Butterfly Supply-Chain Graph, the supply chain is recorded as NONE, with no butterfly links and no proprietary signals. Not available in source data for upstream or downstream dependencies, sector correlations beyond the beta of 0.94, or second-order bottlenecks.

Open Questions

What drives the gap between the 32.8 trailing P/E and the 9.9% ROIC, and what earnings trajectory supports the forward P/E of 30.5?
Why is gross margin reported as 0%, and how should the 13.9% operating margin be interpreted without the underlying income statement?
What is the direction and magnitude of the insider Form 4 and Congressional PTR cluster flows scored in the Insider Conviction pillar?
What institutional accumulation or options positioning underlies the 10 of 20 Whale 13F Flow score?
What revenue, customer, and product mix generates the reported margins and cash flow?

UBS Live News Feed, Press Releases & Catalyst Wire

Real-time company headlines, analyst actions, and sector developments for UBS Group AG Registered (UBS) • Click "Debate This Headline" to argue it in the Roar Pit below

💬 Jump to UBS Debate Forum (3) ↓

🟢 CATALYST Yahoo Finance • 6h ago

UBS Raises AI Spending Forecast To $1.4 Trillion In 2027 — Warns Volatility Is ‘New Normal’

UBS expects AI investment to support global equity returns in 2027 despite concerns over overinvestment, financing and cannibalization, but says greater selectivity is needed.

Read Full Source ↗

🟡 MARKET WIRE Yahoo Finance • 7h ago

Brannon Ozark Joins UBS as Financial Advisor in Hartford, CT

HARTFORD, Conn., November 02, 2026--UBS today announced that Brannon Ozark has joined the firm as a Financial Advisor in the Hartford, CT office. He joins the UBS Greater New York Metro Market and reports to Market Direc

Read Full Source ↗

🟢 CATALYST Yahoo Finance • 7h ago

UBS Boosts Profitability Ambitions as Cost Savings Exceed Expectations

UBS Group reports 16.7% underlying ROCET1 in Q3'26 and expects to exceed its 2026 profitability target, supported by revenue growth and cost savings.

Read Full Source ↗

🔴 RISK WATCH Yahoo Finance • 10h ago

UBS Just Initiated Coverage of Viking Therapeutics With a Buy Rating and a $94 Target. Here's the Bull Case.

Trial results for its weight loss drugs could justify a higher valuation for the clinical-stage biotech.

Read Full Source ↗

🟡 MARKET WIRE Yahoo Finance • 12h ago

Cembra shares slide 8% as UBS flags limited scope for further returns growth

Investing.com -- Shares of Swiss consumer lender Cembra Money Bank AG (SIX:CMBN) fell over 8% on Monday after UBS cut its rating to “sell” from “neutral,” saying the bank has limited scope to keep return on equity above

Read Full Source ↗

🟢 CATALYST Yahoo Finance • 14h ago

UBS (SWX:UBSG) Stock May Look Reasonable On Strong 3Q26 Results

UBS Group has delivered a powerful multi year share price run, which naturally raises the question of whether the current market value is properly grounded in the returns the bank earns on its capital. With investors wat

Read Full Source ↗

🟡 MARKET WIRE Yahoo Finance • 1d ago

What’s next for Euro bonds and the euro after Lagarde’s resignation?

Investing.com -- European bond yields are expected to decline next year, and the euro could recover against the U.S. dollar, as ECB President Christine Lagarde’s early departure is unlikely to alter the central bank’s mo

Read Full Source ↗

🔴 RISK WATCH Yahoo Finance • 3d ago

61% Upside for Pinterest? UBS Thinks So, and Here’s How

Key TakeawaysUBS kept its Buy rating on Pinterest after a third-quarter revenue miss and only trimmed its target to $32 from $33, 61% above the stock’s price. The math behind $32 works, but the stock likely needs revenue

Read Full Source ↗

🔥 THE ROAR PIT • LIVE COMMUNITY DEBATE 3 Active Posts & Replies

UBS Bull vs. Bear Conversation Board — What's Your Call at $47.69?

🐂 50% BULLISH CONVICTION COMMUNITY TUG-OF-WAR ON UBS 🐻 50% BEARISH CONVICTION

RO RoarDesk_Moderator Roarable Research Desk ⚖️ DEBATE HOST 🎯 Target: $51.98 (+8.0%)

📌 Pinned Debate

🔥 Official Bull vs. Bear Debate: Is UBS (D+ • RQD 58/100) a Buy at $48.13?

Welcome to the UBS (UBS Group AG Registered) Roar Pit. Current RQD Composite is 58/100 (Roarable Sell — Weak Fundamentals / Trim) in Major Banks. Bulls point to operating leverage and sector positioning, while bears focus on valuation multiple compression (32.8x trailing P/E). Pick your side (🐂 Bull or 🐻 Bear) and drop your price target below.

RI RiskArb_Desk Forensic Accounting Watch 🐻 BEARISH 🎯 Target: $38.02 (-21.0%)

Spot @ $48.13

Pump the brakes on UBS — check the valuation vs. margin headwinds

Everyone in here is repeating the bull case on UBS, but look at what you are paying: 32.8x trailing P/E with tightening sector spreads. Unless UBS Group AG Registered expands free cash flow yield next quarter, I would rather wait for a pullback closer to the 200-day moving average before touching this.

MI MidwestValue Verified K Arena Trader 🐂 BULLISH 🎯 Target: $59.68 (+24.0%)

Spot @ $48.13

UBS cash flow & RQD setup is being underpriced by the Street here

Looking at the 5-pillar RQD breakdown on UBS, the market is fixating on short-term headline noise in Major Banks and ignoring the balance sheet and cash flow trajectory. At $48.13 (52-wk range $36.29 - $55.99), any beat on forward guidance forces shorts and underweight funds to chase.